LOGIN  |  REGISTER
Assertio

Recent Insider Transactions - Travere Therapeutics (NASDAQ: TVTX)

Follow NASDAQ:TVTX Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ TVTX Travere Therapeutics
Williams Brinkley Ruth / director
05/15/2025
Buy
$21.15
19,500
$412K
19,500
NASDAQ TVTX Travere Therapeutics
Squarer Ron / director
05/15/2025
Buy
$21.15
19,500
$412K
19,500
NASDAQ TVTX Travere Therapeutics
Poole Sandra / director
05/15/2025
Buy
$21.15
19,500
$412K
19,500
NASDAQ TVTX Travere Therapeutics
Orwin John A / director
05/15/2025
Buy
$21.15
19,500
$412K
19,500
NASDAQ TVTX Travere Therapeutics
Meckler Jeffrey A / director
05/15/2025
Buy
$21.15
19,500
$412K
19,500
NASDAQ TVTX Travere Therapeutics
LYONS GARY A / director
05/15/2025
Buy
$21.15
19,500
$412K
19,500
NASDAQ TVTX Travere Therapeutics
COUGHLIN TIMOTHY / director
05/15/2025
Buy
$21.15
19,500
$412K
19,500
NASDAQ TVTX Travere Therapeutics
Bruhn Suzanne Louise / director
05/15/2025
Buy
$21.15
19,500
$412K
19,500
NASDAQ TVTX Travere Therapeutics
Baynes Roy D. / director
05/15/2025
Buy
$21.15
19,500
$412K
19,500
NASDAQ TVTX Travere Therapeutics
Cline Christopher R. / officer: CHIEF FINANCIAL OFFICER
05/05/2025
Sell
$21.05
1,784
$38K
93,126
NASDAQ TVTX Travere Therapeutics
Dube Eric M / director, officer: CHIEF EXECUTIVE OFFICER
05/05/2025
Sell
$21.05
18,924
$398K
419,173
NASDAQ TVTX Travere Therapeutics
Heerma Peter / officer: CHIEF COMMERCIAL OFFICER
05/05/2025
Sell
$21.05
1,771
$37K
128,215
NASDAQ TVTX Travere Therapeutics
ROTE WILLIAM E. / officer: Chief Research Officer
05/05/2025
Sell
$21.05
3,198
$67K
100,241
NASDAQ TVTX Travere Therapeutics
REED ELIZABETH E / officer: Chief Legal Officer and GC
05/05/2025
Sell
$21.05
4,920
$104K
89,482

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous